ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
BlackRock Enhanced Large Cap Core Fund Inc

BlackRock Enhanced Large Cap Core Fund Inc (CII)

20.15
-0.13
(-0.64%)
Closed 12 January 8:00AM
20.13
-0.02
(-0.10%)
After Hours: 11:59AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
20.15
Bid
-
Offer
-
Volume
156,920
20.0101 Day's Range 20.24
17.57 52 Week Range 20.50
Market Cap
Previous Close
20.28
Open
20.24
Last Trade
1183
@
20.15
Last Trade Time
Financial Volume
US$ 3,156,844
VWAP
20.1175
Average Volume (3m)
118,169
Shares Outstanding
148,762,471
Dividend Yield
6.34%
PE Ratio
19.67
Earnings Per Share (EPS)
1.02
Revenue
10.25M
Net Profit
152.21M

About BlackRock Enhanced Large Cap Core Fund Inc

The Trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. The Trust may invest directly in such securities or synthetically through the use of derivatives. The Trust also seeks to achieve its investment objective by employing a ... The Trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. The Trust may invest directly in such securities or synthetically through the use of derivatives. The Trust also seeks to achieve its investment objective by employing a strategy of writing selling call and put options. Show more

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
Wilmington, Delaware, USA
Founded
-
BlackRock Enhanced Large Cap Core Fund Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the New York Stock Exchange with ticker CII. The last closing price for BlackRock Enhanced Large... was US$20.28. Over the last year, BlackRock Enhanced Large... shares have traded in a share price range of US$ 17.57 to US$ 20.50.

BlackRock Enhanced Large... currently has 148,762,471 shares in issue. The market capitalisation of BlackRock Enhanced Large... is US$3.02 billion. BlackRock Enhanced Large... has a price to earnings ratio (PE ratio) of 19.67.

CII Latest News

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below. Municipal Funds: Declaration- 1/2/2025 Ex-Date- 1/15/2025 Record- 1/15/2025 Payable- 2/3/2025...

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced...

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.13-0.64102564102620.2820.520.1310168120.32046904CS
40.140.69965017491320.0120.519.4413063120.13023678CS
120.351.7676767676819.820.519.1411816919.94680425CS
26-0.01-0.049603174603220.1620.517.5711505519.62365692CS
521.186.2203479177618.9720.517.579621819.48790075CS
156-1.42-6.5832174316221.5722.089916.1959011818.8518253CS
2602.7415.738081562317.4122.39.5610017917.88017373CS

CII - Frequently Asked Questions (FAQ)

What is the current BlackRock Enhanced Large... share price?
The current share price of BlackRock Enhanced Large... is US$ 20.15
How many BlackRock Enhanced Large... shares are in issue?
BlackRock Enhanced Large... has 148,762,471 shares in issue
What is the market cap of BlackRock Enhanced Large...?
The market capitalisation of BlackRock Enhanced Large... is USD 3.02B
What is the 1 year trading range for BlackRock Enhanced Large... share price?
BlackRock Enhanced Large... has traded in the range of US$ 17.57 to US$ 20.50 during the past year
What is the PE ratio of BlackRock Enhanced Large...?
The price to earnings ratio of BlackRock Enhanced Large... is 19.67
What is the cash to sales ratio of BlackRock Enhanced Large...?
The cash to sales ratio of BlackRock Enhanced Large... is 292.16
What is the reporting currency for BlackRock Enhanced Large...?
BlackRock Enhanced Large... reports financial results in USD
What is the latest annual turnover for BlackRock Enhanced Large...?
The latest annual turnover of BlackRock Enhanced Large... is USD 10.25M
What is the latest annual profit for BlackRock Enhanced Large...?
The latest annual profit of BlackRock Enhanced Large... is USD 152.21M
What is the registered address of BlackRock Enhanced Large...?
The registered address for BlackRock Enhanced Large... is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
Which industry sector does BlackRock Enhanced Large... operate in?
BlackRock Enhanced Large... operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMPXAmprius Technologies Inc
US$ 3.58
(18.15%)
9.45M
EVCEntravision Communications Corp
US$ 2.65
(16.23%)
1.23M
SSLSasol Ltd
US$ 5.07
(14.71%)
2.45M
OPFIOppFi Inc
US$ 9.285
(12.96%)
4.96M
SVVSavers Value Village Inc
US$ 10.4525
(11.55%)
956.76k
ALURAllurion Technologies Inc
US$ 3.80
(-47.51%)
229.92k
MCYMercury General Corp
US$ 48.68
(-19.80%)
3.49M
SESSES AI Corporation
US$ 1.265
(-18.39%)
18.16M
STZConstellation Brands Inc
US$ 181.81
(-17.09%)
8.7M
GROVGrove Collaborative Holdings Inc
US$ 1.46
(-17.05%)
885.79k
FUBOfuboTV
US$ 5.11
(-4.49%)
98.27M
QBTSD Wave Quantum Inc
US$ 5.765
(-5.49%)
88.86M
FFord Motor Company
US$ 9.65
(-0.92%)
73.35M
PCGPG&E Corporation
US$ 17.16
(-10.86%)
72.59M
IONQIonQ Inc
US$ 32.33
(6.88%)
68.32M

Discussion

View Full Feed
EmpressMonk25 EmpressMonk25 3 minutes ago
If you did your homework, it was clear the company had impressive products; the fault in progress was with Gensler, and the price was actually rock bottom. If you didn’t this, then maybe you weren't watching?
HMBL
jimr1717 jimr1717 4 minutes ago
🏆️ Filed a Form S-1 Registration Statement,
are offering shares of the Company's common stock to the public.
As soon as practicable after the effective date of this Registration Statement.

PROSPECTUS
All Things Mobile Analytic, Inc.
30,000,000 Share
ATMH
jondoeuk jondoeuk 4 minutes ago
KEYNOTE-D58 is a pivotal trial (N=741) of Optune concomitant with temozolomide plus keytruda in ndGBM. The estimated primary completion date is April 2029.
NVCR
Golden Cross Golden Cross 4 minutes ago
$ILLR Triller is the Majority owner of Bare Knuckle Fighting Championship (#BKFC).
This is just one major part of Triller!

1. Triller is Majority Owner of BKFC.
2. World Famous Conor McGregor is Part-Owner
3. $25 Million Tournament Coming up!
4. BKFC is the
ILLR
Golden Cross Golden Cross 6 minutes ago
$ILLR Triller is the Majority owner of Bare Knuckle Fighting Championship (#BKFC).
This is just one major part of Triller!

1. Triller is Majority Owner of BKFC.
2. World Famous Conor McGregor is Part-Owner
3. $25 Million Tournament Coming up!
4. BKFC is the
ILLR
Kool Aid Man Kool Aid Man 6 minutes ago
I can't wait for the PR explaining the need for 700 million more shares. Never ending source of entertainment
SPZI
dstock07734 dstock07734 7 minutes ago
Gary,

I strongly suggest you go through the details of all the outcome measures adopted in the combo trial. They are so disruptive. I also think we should abandon the old concept about the definition of phase on clinical trials. The phase definition for DCVax-L doesn't matter. What it
NWBO
manibiotech manibiotech 7 minutes ago
Yep you did get it straight .
There is a reason companies apply to FDA and EMA . And there is reason for current SP.
But problem is that when given  straight to you , you can't comprehend straightforward reasons 
NWBO
Lime Time Lime Time 8 minutes ago
Very good opportunity
GVSI
gshores gshores 12 minutes ago
Nothing personal, but you reek of desperation for some reason. Longs will do great here.
SPZI
jondoeuk jondoeuk 13 minutes ago
Data from the PhII 2-THE-TOP trial https://www.onclive.com/view/temozolomide-pembrolizumab-plus-ttfields-leads-to-tumor-control-in-newly-diagnosed-glioblastoma
NVCR
kBletsgo30 kBletsgo30 14 minutes ago
Yeah right 
RSPI
ddls ddls 15 minutes ago
Maybe you should double down, buy 10M shares...😎

Just watch out for these types of days..."1/3/25, Buy: 1,300,000, Neutral: 366,005, Sell: 66,963,117.😎

You'll be seeing more of them.
BIEL
XMaster2023 XMaster2023 19 minutes ago
I would take your bet but you have the ethics of someone who would work for an idiot who would try to kill a cure for cancer. Thus, I would never trust you!
NWBO
manibiotech manibiotech 21 minutes ago
And someone to pay NWBO ( not advent ) for those treatments 
NWBO
StockItOut StockItOut 23 minutes ago
Are they really? That's evidence of a scam.
XERI
skitahoe skitahoe 24 minutes ago
Dstocks, it's clear that many are interested in the kind of work we're doing. My question is, are any beyond the Phase 1/2 trials.

I believe we're clearly the leaders here and with approvals while it may make it easier for others, they'll still be many years before the can possibly g
NWBO
vinmantoo vinmantoo 25 minutes ago
Have you seen the stock price?

Enough said.

The stock price alone certainly isn't enough said.
Eagle1 Eagle1 29 minutes ago
SDCRBS, Please let me know if I can help you in any way. Just DM me. I'm sorry and sad to see all this CA and LA destruction.

I'm in the Houston area and couldn't imagine this type of destruction.

So Sorry.
GDVM
Plasmode Plasmode 33 minutes ago
I’ve learned so much from valuable contributors like Mr C and Dino and great respects for your researches and insights, then this kind of bickering just knock you off the pedestal into muck. Just respond with ‘next’ if you refuse to lower yourself into the mud. I have more respect for people like
TGLO
elks elks 33 minutes ago
Tic toc
GVSI
jondoeuk jondoeuk 35 minutes ago
Translational data from the PhI B-cell lymphomas trial demonstrated primary, secondary and tertiary tissue trafficking and clearance of CD19+ cells. That should help enable an immune reset in autoimmune diseases.

The next-gen CAR-T's will incorporate a suite of novel synthetic edits t
FATE
elks elks 36 minutes ago
Agreed
HMBL
gimmee greenbacks gimmee greenbacks 37 minutes ago
Testify 3331!

Biel Gonna. R U N in 2025!!!!!!




BIEL
BIEL
Dieselsmoke Dieselsmoke 39 minutes ago
Let her fly
RGTI

Your Recent History

Delayed Upgrade Clock